Search Results - "Col, Valentina Dal"
-
1
Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing
Published in Small (Weinheim an der Bergstrasse, Germany) (01-07-2016)“…Self‐assembly is a fundamental concept and a powerful approach in molecular science. However, creating functional materials with the desired properties through…”
Get full text
Journal Article -
2
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Published in Molecular oncology (01-02-2015)“…Basal cell carcinomas (BCCs) and a subset of medulloblastomas are characterized by loss-of-function mutations in the tumor suppressor gene, PTCH1. PTCH1…”
Get full text
Journal Article -
3
Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC-33 Compounds: Promising Neuroprotective Agents Acting as σ1 Receptor Agonists
Published in ChemMedChem (01-09-2013)“…Our recent research efforts identified racemic RC‐33 as a potent and metabolically stable σ1 receptor agonist. Herein we describe the isolation of pure RC‐33…”
Get full text
Journal Article -
4
Are two better than one? A novel double-mutant KIT in GIST that responds to Imatinib
Published in Molecular oncology (01-08-2013)“…Gastrointestinal stromal tumors carry in about 85% of the cases activating mutations in KIT gene. Generally only one KIT mutation is found in primary tumors…”
Get full text
Journal Article -
5
Another Brick in the Wall. Validation of the σ1 Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1 Ligands
Published in Molecular pharmaceutics (05-11-2012)“…Originally considered an enigmatic polypeptide, the σ1 receptor has recently been identified as a unique ligand-regulated protein. Many studies have shown the…”
Get full text
Journal Article -
6
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor
Published in ACS medicinal chemistry letters (10-11-2011)“…This study presents for the first time the 3D model of the σ1 receptor protein as obtained from homology modeling techniques, shows the applicability of this…”
Get full text
Journal Article -
7
Pd-Catalyzed Direct C–H Bond Functionalization of Spirocyclic σ1 Ligands: Generation of a Pharmacophore Model and Analysis of the Reverse Binding Mode by Docking into a 3D Homology Model of the σ1 Receptor
Published in Journal of medicinal chemistry (27-09-2012)“…To explore the hydrophobic binding region of the σ1 receptor protein, regioisomeric spirocyclic thiophenes 9–11 were developed as versatile building blocks…”
Get full text
Journal Article -
8
Homology Model and Docking-Based Virtual Screening for Ligands of the σ 1 Receptor
Published in ACS medicinal chemistry letters (10-11-2011)Get full text
Journal Article -
9
Synthesis, Pharmacological Evaluation, and σ1 Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines
Published in Journal of medicinal chemistry (10-04-2014)“…Starting from (S)- or (R)-aspartate, three synthetic strategies were explored to prepare hydroxyethyl substituted piperazines with different substituents at…”
Get full text
Journal Article -
10
Synthesis, Pharmacological Evaluation, and σ 1 Receptor Interaction Analysis of Hydroxyethyl Substituted Piperazines
Published in Journal of medicinal chemistry (10-04-2014)Get full text
Journal Article -
11
siRNA Delivery: Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing (Small 27/2016)
Published in Small (Weinheim an der Bergstrasse, Germany) (20-07-2016)“…Supramolecular dendrimers created from small amphiphilic dendrons are able to mimic covalently constructed high‐generation dendrimers for siRNA delivery, as…”
Get full text
Journal Article -
12
Abstract PR05: Resistance to Hedgehog inhibitor through Smoothened receptor mutation in basal cell carcinoma
Published in Molecular cancer therapeutics (01-11-2013)“…Abstract The inappropriate activation of Hedgehog (Hh) pathway is involved in the pathogenesis of skin basal cell carcinoma (BCC). Loss of function of the…”
Get full text
Journal Article -
13
-
14
Another Brick in the Wall. Validation of the σ 1 Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ 1 Ligands
Published in Molecular pharmaceutics (05-11-2012)Get full text
Journal Article -
15
2-Difluoromethylene-4-methylenepentanoic Acid, A Paradoxical Probe Able To Mimic the Signaling Role of 2-Oxoglutaric Acid in Cyanobacteria
Published in Organic letters (03-06-2011)“…2-Difluoromethylene-4-methylenepentanoic acid (DFMPA), a seemingly deviated analog of 2-oxoglutaric acid (2-OG), could surprisingly mimic its signaling…”
Get full text
Journal Article -
16
Target sequencing approach intended to discover new mutations in non-syndromic intellectual disability
Published in Mutation research (01-11-2015)“…The technological improvements over the last years made considerable progresses in the knowledge of the etiology of intellectual Disability (ID). However, at…”
Get more information
Journal Article -
17
Chemical, Pharmacological, and in vitro Metabolic Stability Studies on Enantiomerically Pure RC‐33 Compounds: Promising Neuroprotective Agents Acting as σ 1 Receptor Agonists
Published in ChemMedChem (01-09-2013)“…Abstract Our recent research efforts identified racemic RC‐33 as a potent and metabolically stable σ 1 receptor agonist. Herein we describe the isolation of…”
Get full text
Journal Article -
18